Australia markets closed

iRhythm Technologies, Inc. (IRTC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
134.63+7.12 (+5.58%)
At close: 04:00PM EDT
134.50 -0.13 (-0.10%)
After hours: 05:33PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close127.51
Open131.65
Bid0.00 x 900
Ask0.00 x 800
Day's range131.65 - 136.28
52-week range58.41 - 169.54
Volume503,375
Avg. volume414,471
Market cap4.042B
Beta (5Y monthly)1.50
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day

    SAN FRANCISCO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent and predict disease, will discuss the Company’s strategies for long-term growth, provide an update on its innovation pipeline and share its financial goals during its 2022 Analyst & Investor Day today in New York City. A live webcast of the event will begin at 9:00 a.m. ET and will be accessible at that time

  • GlobeNewswire

    iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022

    SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the Company will host an Analyst & Investor Day on Wednesday, September 21, 2022, in New York City. A live webcast of the event will begin at 9:00 a.m. ET and will be accessible at that time on the investors section of the Company’s website at investors.irhythmtech.com. A replay of the webcast and r

  • GlobeNewswire

    iRhythm Technologies Announces Second Quarter 2022 Financial Results

    SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022. Second Quarter 2022 Financial Highlights Revenue of $102.1 million, a 25.6% increase compared to second quarter 2021Gross margin of 68.8%, a 0.8 percentage point improvement compared to second quarter 2021Cash and short-term investments of $2